Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 87

1.

Model-based approach for methoxy polyethylene glycol-epoetin beta drug development in paediatric patients with anaemia of chronic kidney disease.

Chanu P, Schaefer F, Warady BA, Schmitt CP, Reigner B, Schnetzler G, Meyer Reigner S, Eisner M, Weichert A, Frey N.

Br J Clin Pharmacol. 2020 Apr;86(4):801-811. doi: 10.1111/bcp.14186. Epub 2020 Jan 21.

PMID:
31770451
2.

Encapsulating Peritoneal Sclerosis: Pathophysiology and Current Treatment Options.

Jagirdar RM, Bozikas A, Zarogiannis SG, Bartosova M, Schmitt CP, Liakopoulos V.

Int J Mol Sci. 2019 Nov 16;20(22). pii: E5765. doi: 10.3390/ijms20225765. Review.

3.

Cinacalcet use in paediatric dialysis: a position statement from the European Society for Paediatric Nephrology and the Chronic Kidney Disease-Mineral and Bone Disorders Working Group of the ERA-EDTA.

Bacchetta J, Schmitt CP, Ariceta G, Bakkaloglu SA, Groothoff J, Wan M, Vervloet M, Shroff R, Haffner D; European Society for Paediatric Nephrology and the Chronic Kidney Disease-Mineral and Bone Disorders and Dialysis Working Group of the ERA-EDTA.

Nephrol Dial Transplant. 2020 Jan 1;35(1):47-64. doi: 10.1093/ndt/gfz159.

PMID:
31641778
4.

Haemodiafiltration does not lower protein-bound uraemic toxin levels compared with haemodialysis in a paediatric population.

Snauwaert E, Van Biesen W, Raes A, Glorieux G, Vande Walle J, Roels S, Vanholder R, Askiti V, Azukaitis K, Bayazit A, Canpolat N, Fischbach M, Saoussen K, Litwin M, Obrycki L, Paglialonga F, Ranchin B, Samaille C, Schaefer F, Schmitt CP, Spasojevic B, Stefanidis CJ, Shroff R, Eloot S.

Nephrol Dial Transplant. 2019 Jul 30. pii: gfz132. doi: 10.1093/ndt/gfz132. [Epub ahead of print]

PMID:
31361315
5.

Arterial tissue transcriptional profiles associate with tissue remodeling and cardiovascular phenotype in children with end-stage kidney disease.

Freise C, Schaefer B, Bartosova M, Bayazit A, Bauer U, Pickardt T, Berger F, Rasmussen LM, Jensen PS, Laube G, Mencarelli F, Arbeiter K, Büscher R, Habbig S, Möller K, Kirchner M, Schaefer F, Schmitt CP, Querfeld U.

Sci Rep. 2019 Jul 16;9(1):10316. doi: 10.1038/s41598-019-46805-5.

6.

Analysis of the Ribonuclease A Superfamily of Antimicrobial Peptides in Patients Undergoing Chronic Peritoneal Dialysis.

Pottanat ND, Brook AC, Bartosova M, Cortado H, Gupta S, Li B, Jackson AR, Vonau M, Cohen S, Ferrara M, Ching CB, Spencer JD, Brauner A, Fraser DJ, Schmitt CP, Eberl M, Ayoob R, Becknell B.

Sci Rep. 2019 May 23;9(1):7753. doi: 10.1038/s41598-019-44219-x.

7.

CNDP1 knockout in zebrafish alters the amino acid metabolism, restrains weight gain, but does not protect from diabetic complications.

Schmöhl F, Peters V, Schmitt CP, Poschet G, Büttner M, Li X, Weigand T, Poth T, Volk N, Morgenstern J, Fleming T, Nawroth PP, Kroll J.

Cell Mol Life Sci. 2019 Nov;76(22):4551-4568. doi: 10.1007/s00018-019-03127-z. Epub 2019 May 9.

PMID:
31073745
8.

Uremic Toxin Concentrations are Related to Residual Kidney Function in the Pediatric Hemodialysis Population.

Snauwaert E, Holvoet E, Van Biesen W, Raes A, Glorieux G, Vande Walle J, Roels S, Vanholder R, Askiti V, Azukaitis K, Bayazit A, Canpolat N, Fischbach M, Godefroid N, Krid S, Litwin M, Obrycki L, Paglialonga F, Ranchin B, Samaille C, Schaefer F, Schmitt CP, Spasojevic B, Stefanidis CJ, Van Dyck M, Van Hoeck K, Collard L, Eloot S, Shroff R.

Toxins (Basel). 2019 Apr 24;11(4). pii: E235. doi: 10.3390/toxins11040235.

9.

Vascular Access Choice, Complications, and Outcomes in Children on Maintenance Hemodialysis: Findings From the International Pediatric Hemodialysis Network (IPHN) Registry.

Borzych-Duzalka D, Shroff R, Ariceta G, Yap YC, Paglialonga F, Xu H, Kang HG, Thumfart J, Aysun KB, Stefanidis CJ, Fila M, Sever L, Vondrak K, Szabo AJ, Szczepanska M, Ranchin B, Holtta T, Zaloszyc A, Bilge I, Warady BA, Schaefer F, Schmitt CP.

Am J Kidney Dis. 2019 Aug;74(2):193-202. doi: 10.1053/j.ajkd.2019.02.014. Epub 2019 Apr 19.

PMID:
31010601
10.

Peritoneal Dialysis Vintage and Glucose Exposure but Not Peritonitis Episodes Drive Peritoneal Membrane Transformation During the First Years of PD.

Bartosova M, Schaefer B, Vondrak K, Sallay P, Taylan C, Cerkauskiene R, Dzierzega M, Milosevski-Lomic G, Büscher R, Zaloszyc A, Romero P, Lasitschka F, Warady BA, Schaefer F, Ujszaszi A, Schmitt CP.

Front Physiol. 2019 Apr 2;10:356. doi: 10.3389/fphys.2019.00356. eCollection 2019.

11.

Acute dialysis in children: results of a European survey.

Guzzo I, de Galasso L, Mir S, Bulut IK, Jankauskiene A, Burokiene V, Cvetkovic M, Kostic M, Bayazit AK, Yildizdas D, Schmitt CP, Paglialonga F, Montini G, Yilmaz E, Oh J, Weber L, Taylan C, Hayes W, Shroff R, Vidal E, Murer L, Mencarelli F, Pasini A, Teixeira A, Afonso AC, Drozdz D, Schaefer F, Picca S; ESCAPE Network.

J Nephrol. 2019 Jun;32(3):445-451. doi: 10.1007/s40620-019-00606-1. Epub 2019 Apr 4.

PMID:
30949986
12.

Carnosine and diabetic nephropathy.

Peters V, Yard B, Schmitt CP.

Curr Med Chem. 2019 Mar 25. doi: 10.2174/0929867326666190326111851. [Epub ahead of print]

PMID:
30914013
13.

Effects of Hemodiafiltration versus Conventional Hemodialysis in Children with ESKD: The HDF, Heart and Height Study.

Shroff R, Smith C, Ranchin B, Bayazit AK, Stefanidis CJ, Askiti V, Azukaitis K, Canpolat N, Ağbaş A, Aitkenhead H, Anarat A, Aoun B, Aofolaju D, Bakkaloglu SA, Bhowruth D, Borzych-Dużałka D, Bulut IK, Büscher R, Deanfield J, Dempster C, Duzova A, Habbig S, Hayes W, Hegde S, Krid S, Licht C, Litwin M, Mayes M, Mir S, Nemec R, Obrycki L, Paglialonga F, Picca S, Samaille C, Shenoy M, Sinha MD, Spasojevic B, Stronach L, Vidal E, Vondrák K, Yilmaz A, Zaloszyc A, Fischbach M, Schmitt CP, Schaefer F.

J Am Soc Nephrol. 2019 Apr;30(4):678-691. doi: 10.1681/ASN.2018100990. Epub 2019 Mar 7.

14.

Biocompatible Peritoneal Dialysis: The Target Is Still Way Off.

Bartosova M, Schmitt CP.

Front Physiol. 2019 Jan 7;9:1853. doi: 10.3389/fphys.2018.01853. eCollection 2018. Review.

15.

Carnosinase concentration, activity, and CNDP1 genotype in patients with type 2 diabetes with and without nephropathy.

Zhang S, Albrecht T, Rodriguez-Niño A, Qiu J, Schnuelle P, Peters V, Schmitt CP, van den Born J, Bakker SJL, Lammert A, Krämer BK, Yard BA, Hauske SJ.

Amino Acids. 2019 Apr;51(4):611-617. doi: 10.1007/s00726-018-02692-0. Epub 2019 Jan 4.

PMID:
30610469
16.

Infants with congenital nephrotic syndrome have comparable outcomes to infants with other renal diseases.

Dufek S, Ylinen E, Trautmann A, Alpay H, Ariceta G, Aufricht C, Bacchetta J, Bakkaloglu S, Bayazit A, Caliskan S, do Sameiro Faria M, Dursun I, Ekim M, Jankauskiene A, Klaus G, Paglialonga F, Pasini A, Printza N, Conti VS, Schmitt CP, Stefanidis C, Verrina E, Vidal E, Webb H, Zampetoglou A, Edefonti A, Holtta T, Shroff R; ESPN Dialysis Working Group.

Pediatr Nephrol. 2019 Apr;34(4):649-655. doi: 10.1007/s00467-018-4122-0. Epub 2018 Oct 29.

PMID:
30374605
17.

Protective Actions of Anserine Under Diabetic Conditions.

Peters V, Calabrese V, Forsberg E, Volk N, Fleming T, Baelde H, Weigand T, Thiel C, Trovato A, Scuto M, Modafferi S, Schmitt CP.

Int J Mol Sci. 2018 Sep 13;19(9). pii: E2751. doi: 10.3390/ijms19092751.

18.

Management of children with congenital nephrotic syndrome: challenging treatment paradigms.

Dufek S, Holtta T, Trautmann A, Ylinen E, Alpay H, Ariceta G, Aufricht C, Bacchetta J, Bakkaloglu SA, Bayazit A, Cicek RY, Dursun I, Duzova A, Ekim M, Iancu D, Jankauskiene A, Klaus G, Paglialonga F, Pasini A, Printza N, Said Conti V, do Sameiro Faria M, Schmitt CP, Stefanidis CJ, Verrina E, Vidal E, Vondrak K, Webb H, Zampetoglou A, Bockenhauer D, Edefonti A, Shroff R.

Nephrol Dial Transplant. 2019 Aug 1;34(8):1369-1377. doi: 10.1093/ndt/gfy165.

PMID:
30215773
19.

Chronic dialysis in children and adolescents: challenges and outcomes.

Rees L, Schaefer F, Schmitt CP, Shroff R, Warady BA.

Lancet Child Adolesc Health. 2017 Sep;1(1):68-77. doi: 10.1016/S2352-4642(17)30018-4. Epub 2017 Jul 20. Review.

PMID:
30169229
20.

Effect of haemodiafiltration vs conventional haemodialysis on growth and cardiovascular outcomes in children - the HDF, heart and height (3H) study.

Shroff R, Bayazit A, Stefanidis CJ, Askiti V, Azukaitis K, Canpolat N, Agbas A, Anarat A, Aoun B, Bakkaloglu S, Bhowruth D, Borzych-Dużałka D, Bulut IK, Büscher R, Dempster C, Duzova A, Habbig S, Hayes W, Hegde S, Krid S, Licht C, Litwin M, Mayes M, Mir S, Nemec R, Obrycki L, Paglialonga F, Picca S, Ranchin B, Samaille C, Shenoy M, Sinha M, Smith C, Spasojevic B, Vidal E, Vondrák K, Yilmaz A, Zaloszyc A, Fischbach M, Schaefer F, Schmitt CP.

BMC Nephrol. 2018 Aug 10;19(1):199. doi: 10.1186/s12882-018-0998-y.

Supplemental Content

Loading ...
Support Center